Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Transgene
Biotech
2019’s top 15 clinical trial flops (and a flip-flop)
The catalog includes multiple trials for aggressive brain cancer, Alzheimer’s disease and nonalcoholic steatohepatitis.
Phil Taylor
Dec 16, 2019 6:00am
Korean prosecutors raid SillaJen over suspected insider trading
Aug 29, 2019 11:02am
Phase 3 trial of Transgene's oncolytic virus halted for futility
Aug 2, 2019 7:50am
EuroBiotech: More Articles of Note
May 16, 2019 9:53am
AstraZeneca ups oncolytic virus activity with Transgene deal
May 2, 2019 9:22am
Merck KGaA in Transgene cancer vaccine-checkpoint inhibitor test tie-up
Oct 12, 2016 4:18am
